Follow
Komal Sangu
Komal Sangu
PhD Research scholar
Verified email at csiriict.in
Title
Cited by
Cited by
Year
Evading antimicrobial resistance using boron-containing therapeutics
K G Sangu, A U Shinde, S Chopra, H B Rode
Future Medicinal Chemistry 13 (03), 229-232, 2021
62021
Nitazoxanide potentiates linezolid against linezolid-resistant Staphylococcus aureus in vitro and in vivo
G Kaul, A Akhir, M Shukla, KS Rawat, CP Sharma, KG Sangu, HB Rode, ...
Journal of Antimicrobial Chemotherapy 77 (9), 2456-2460, 2022
52022
3‐Aryl‐substituted imidazo[1,2‐a]pyridines as antituberculosis agents
UB Karale, AU Shinde, DA Babar, KG Sangu, SK Vagolu, VK Eruva, ...
Archiv der Pharmazie 354 (10), 2000419, 2021
52021
Oxidative Dearomatization as a Strategy for a Facile, Metal‐Free Synthesis of Vanillyl Benzodiazepines
SN Nunewar, KG Sangu, NK Kotla, ND Tangellamudi
ChemistrySelect 5 (32), 10015-10021, 2020
32020
Synthesis and Bio‐evaluation of GR135486X Derivatives as Potent Anti‐Tubercular Agents
KG Sangu, S Dasugari varakala, EV Krishna, A Akhir, D Saxena, ...
ChemistrySelect 8 (1), e202204186, 2023
2023
Synthesis and evaluation of novel almazole D analogs as anticancer agents
AP Oluyori, T Harini, KG Sangu, EV Krishna, SS Jadav, S Misra, HB Rode
Archiv der Pharmazie 355 (11), 2200102, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–6